Structure-based drug discovery of GPCR purine receptor ligands with Kenneth Jacobson

At the 256th National Meeting and Exposition of the American Chemical Society, we spoke to Kenneth A Jacobson, Senior Investigator at the NIDDK. Learn more about his group's research into GPCR drug discovery and the potential therapeutic benefits of these ligands.

Thumb untitled design
Sep 25, 2018
0
0

At the recent 256th National Meeting and Exposition of the American Chemical Society (MA, USA, 19–23 August), we were fortunate to speak to Kenneth A Jacobson, Senior Investigator at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK; MA, USA), part of the National Institutes of Health (NIH). 

You can catch up with all our content from ACS here, including top news stories and daily updates. In addition, we'd love to hear from you! Tweet us @MedChemNet to let us know your top tips and conference highlights. 

Medium untitled design

RxNet

A network for the drug discovery and development community, Future Science Group

Your source for the latest news and views from the fields of drug discovery and medicinal chemistry.

No comments yet.